Zeus, Inc., a global leader in material science and high performance polymer extrusions, announces it has expanded its capabilities and is now able to process Aeos®ePTFE and Electrospun Polymers in a new 5,000 sq. ft. Class 7 manufacturing environment. This expansion allows for the processing of these advanced materials in a more controlled environment, resulting in compliance with stricter regulatory standards.

"Medical regulatory bodies are raising the bar on standards for devices in the industry and Zeus is committed to meeting this challenge," said Bob Jennings, Zeus Vice-president, Sales and Marketing. "The processing of these advanced materials in a tightly controlled environment ensures that customer products meet the strictest regulatory requirements in the medical device industry."
Zeus is also equipped with a Class 7 Certified 5,000 sq. ft. Biomaterials Facility dedicated exclusively to the extrusion, analysis, and characterization of bioabsorbable polymers and other advanced materials. Coupled with the state-of-the-art Biomaterials Facility, this latest Class 7 expansion further boosts Zeus’ ability to provide its customers a speed to market pathway for their products. This brings Zeus’ total Class 7 Certified manufacturing capabilities to 10,000 sq. ft. of controlled environment operating under ISO 13485 guidelines.

"Zeus is leading the charge in the marketplace by providing support from ideation all the way to polymer characterization for medical device companies," said Bob Ballard, Vice President, Research and Strategic Business Development. "In addition to our ability to process and extrude polymers in a Class 7 environment, we also have a dedicated analytical laboratory that allows us to provide real-time analysis and characterization of polymers while being manufactured."